<SEC-DOCUMENT>0001193805-20-000138.txt : 20200211
<SEC-HEADER>0001193805-20-000138.hdr.sgml : 20200211
<ACCEPTANCE-DATETIME>20200211160520
ACCESSION NUMBER:		0001193805-20-000138
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200211
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200211
DATE AS OF CHANGE:		20200211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADMA BIOLOGICS, INC.
		CENTRAL INDEX KEY:			0001368514
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				562590442
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36728
		FILM NUMBER:		20596554

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446
		BUSINESS PHONE:		(201) 478-5552

	MAIL ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	R&R ACQUISITION VI, INC
		DATE OF NAME CHANGE:	20060707
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>e619339_8k-adma.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 11pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 11pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 11pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>FORM 8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<U>February 11, 2020</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 18pt"><B>ADMA BIOLOGICS,
    INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: center">(Exact name of registrant as specified in its charter)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 34%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 33%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Delaware</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">001-36728</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">56-2590442</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center">465 State Route 17, Ramsey, New Jersey </TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center">07446</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="text-align: center">(Address of principal executive offices)</TD>
    <TD STYLE="text-align: center">(Zip Code)</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <U>(201) 478-5552</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">(Former name or former address, if changed since last report.)</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">o</FONT> Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%; border: Black 1pt solid; text-align: center">Title of each class</TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Trading Symbol(s)</TD>
    <TD STYLE="width: 40%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Name of each exchange on which registered</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">Common stock, par value $0.0001 per share</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">ADMA</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Nasdaq Global Market</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px"><B>Item 8.01</B></TD>
    <TD><B>Other Events.</B></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 11, 2020, ADMA Biologics, Inc., a Delaware corporation
(the &ldquo;Company&rdquo;), announced that it has completed its previously announced sale of an aggregate of 23,500,000 shares
of common stock, $0.0001 par value per share (the &ldquo;Common Stock&rdquo;), pursuant to the Company&rsquo;s existing shelf registration
statement on Form S-3 (File No. 333-234107) (the &ldquo;Offering&rdquo;). The Company received gross proceeds of $82,250,000, before
deducting the underwriting discounts and commissions and estimated fees and expenses payable by the Company in connection with
the Offering. Morgan Stanley &amp; Co. LLC and Jefferies LLC acted as joint book-running managers for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><B>Item 9.01</B></TD>
    <TD><B>Financial Statements and Exhibits.</B></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%"><P STYLE="margin-top: 0; margin-bottom: 0"><U>Exhibit</U></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><U>No.</U></P></TD>
    <TD STYLE="width: 91%"><U>Description</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>5.1</TD>
    <TD><A HREF="e619339_ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of Morgan, Lewis &amp; Bockius LLP.</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>23.1</TD>
    <TD><A HREF="e619339_ex5-1.htm" STYLE="-sec-extract: exhibit">Consent of Morgan, Lewis &amp; Bockius LLP (included in Exhibit 5.1).</A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>SIGNATURE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>February 11, 2020</TD>
    <TD COLSPAN="3">ADMA Biologics, Inc.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">/s/ Brian Lenz</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 40%">Brian Lenz</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="border-bottom: Black 2px solid; text-align: center; margin-top: 0; margin-bottom: 0">3</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>e619339_ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 11, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADMA Biologics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">465 Route 17</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ramsey, NJ 07446</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>ADMA Biologics, Inc., Registration Statement on Form S-3 (File No.&nbsp;333-234107)</U></FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have acted as counsel for ADMA Biologics, Inc., a Delaware
corporation (the &ldquo;Company&rdquo;), in connection with the offering and sale by the Company of 23,500,000 shares (the &ldquo;Shares&rdquo;)
of common stock, $0.0001 par value per share, of the Company (the &ldquo;Common Stock&rdquo;) pursuant to that certain Underwriting
Agreement, dated February 6, 2020, by and among the Company and Morgan Stanley &amp; Co. LLC and Jefferies LLC, as representatives
of the several underwriters named therein (the &ldquo;Underwriting Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with this opinion letter, we have examined the
Company&rsquo;s registration statement on Form&nbsp;S-3 (Registration No. 333-234107) (the &ldquo;Registration Statement&rdquo;)
filed by the Company with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under the Securities Act of 1933,
as amended (the &ldquo;Securities Act&rdquo;), which was declared effective on October 15, 2019, the Prospectus Supplement, dated
February 6, 2020 (the &ldquo;Prospectus Supplement&rdquo;) and the accompanying base prospectus dated October 15, 2019 (the &ldquo;Base
Prospectus&rdquo;) and originals, or copies certified or otherwise identified to our satisfaction, of the Second Amended and Restated
Certificate of Incorporation, as amended, the Amended and Restated Bylaws of the Company, the Underwriting Agreement, and such
other documents, records and other instruments as we have deemed appropriate for purposes of the opinion set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have assumed the genuineness of all signatures, the legal
capacity of all natural persons, the authenticity of the documents submitted to us as originals, the conformity with the originals
of all documents submitted to us as certified, facsimile or photostatic copies and the authenticity of the originals of all documents
submitted to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based upon the foregoing, we are of the opinion that the Shares,
when issued and sold by the Company and delivered by the Company against receipt of the purchase price therefor, in the manner
contemplated by the Prospectus Supplement and the Underwriting Agreement will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our opinion is limited solely to the Delaware General Corporation
Law without regard to choice of law, to the extent that the same may apply to or govern the transactions contemplated by the Registration
Statement. We express no opinion as to the effect of events occurring, circumstances arising, or changes of law becoming effective
or occurring, after the date hereof on the matters addressed in this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the use of this opinion as Exhibit 5.1
to the Registration Statement and to the reference to us under the caption &ldquo;Legal Matters&rdquo; in the Prospectus Supplement.
In giving such consent, we do not hereby admit that we are acting within the category of persons whose consent is required under
Section&nbsp;7 of the Securities Act or the rules or regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Morgan, Lewis &amp; Bockius LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;<IMG SRC="logo2.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K -T# 2(  A$! Q$!_\0
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2$T_^LDCB56D^I R:M444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !* 2 # 2(  A$! Q$!_\0
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MP1J,_P -M>N=&O(KJ0QV=\VH1V,EE';&0!O-ED$>P;S\AR0#]3**_!O]B?\
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M2Z-J.JZC)IV@:+XJN])UN;3UM+1]6U^S^P22Q1+*S+)J3Q>>I\AU7Y_T_HH
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M:7Q+9)'XFF$BQF.Q8R8N7\QT3;%N.YU'4B@#T>BN6^,'QS\$_L\^#CXB\?\
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MP7)U@A%DFB57\M3(/J/]H[_@H5HGP,_:P\#_  @CN_AS:^(_%5O;ZE<-XO\
M&\/AH?9)[S[)%'I\9AGEU"^DD6;9;HD:'R</-&7C#\Q\7/V_?B1\!?B#XIT;
MQ-\,OA[/!I&C1ZEI\NB?$*ZN[AI[W4H],T6"_BFTB!;-;ZY:51)')<>6+.Y(
M63R_F /#?'W[+OQAUC4O''CN+X2>(M7_ .%LZ3XZT"'P3=:QH277A ZQ#HEO
M;7-V_P!L-H8)3I%Q+/\ 99KB51>1XCD;S%7]#O 'A^X\)>!-%TJ[O'U"ZTRP
M@M)KI_O7+QQJK2'W8@G\:^;IO^"C6M^&O!>E/KOPR8^*(_BAI_PO\36VB>(X
M;[2/#=S>75FD-U]KGBMKBXB:VO[:55CL]_F.8W$:@S5]44 >!_M$_P#!/S0_
MVB_'>M:O<^-/'OAJP\8Z39Z#XOT/1IK#^SO%^GVLMQ)';7/VFTFGA!6ZN8W>
MSEMY'CEPSDI&4QOB_P#\$LOA]\:O!GB+0]4UCQC!:>)K[Q1?W3VEW;+)')X@
MTVXTZ\"%H& 5(;EVBR"5<*6,@!4_2M% 'R3\<?\ @CI\/?V@FUM/$'B3Q3=V
M&I>((_$]AIM[I/A[5[#0=0^QBSGEMX-0TRX27SX0-ZW8G5& :$0L :O:!_P2
M=\*>$_$?AR?2?'GC_2-"T34]"UV[\-Z?::#9Z/K>I:/!;V]I=RQ1::K6Y,5I
M;(\-B]M;XA&V)"6)^J** /&OVHOV/G_:N6;2]9^)?Q"T7P+JE@NFZWX/TB+1
MUTS7X#(S2K/-/82W\?FHPB8VUU"0BJ4\M\N?&/VAO^")/P__ &F-,U'2_$GC
MKXA3>';W7-9UZWT26R\.ZA8:7/J\S3WWV=+S2IV5VF=WCG9FN;?S'6&:)'93
M]F44 ?)'Q=_X(W_#KXU:'KNDZUXC\676BZQK6G>)K;2[S3]!U6PTC5K/2XM)
M^W107VFSI*\ME%Y3QW0GA4NTD4<4@1UT?A;_ ,$E_ ?PI^.?P]\>V6MZJVI?
M#33O[,TJVMO#/A?1XGB\BXA*R3:=I-M="(_:I9#;1SI;&0AO)XQ7U-10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %<E\=/@9X4_:5^$^M^!_&^BVOB
M#POXAMS;7UC<9VR+D$$$$,KJP#*RD,K*"""*ZVB@#X7^ /\ P;T? #X#_'[3
M/B-+-X^\=:UH!A.BV_BW6UU&ST<0 "W6)!$C,L( $:RLZIM&!D C[.\<?#S1
M_B19V%OK5G]LBTO4K75K5?->/RKJVE66&3*$$[753M.5.,$$<5M44 >2?$W]
MD[_A9?[47@7XHGX@>.=%N? -G<V-GH&GQZ6=)O4N64W)G\ZRDNBTJQP(?+N$
M"B!-@1FD9^$\8_\ !,3P[XYM]+BO_B'\5+B,::FA^)C<ZC97LOCO3([^2^AL
M=2EN+2201Q//<HCV;6TPCN74R'$93Z6HH ^?O!__  3WTKX?^/=9\0:+\0?B
M'83SV^NP^';8'2Y;;P.^LWT=_J$VGI)8L7=[F)&07INDA4&.)4B9HSM?#K]B
MZR^&']ESZ=X]^)#:K;7FJ:KJVHRZE;^9XIU"_B6)[O4(E@%O(\(2/R(TBCAA
M$:*L010E>ST4 ?-OC3_@FOI?C_\ 9_\ ''@?5/B?\4KG4OB7=QW/BCQ<TFD'
M6]7CCC6&.VVG3S96\"Q(BA+>UBP0SY\R25W[35/V2V\8>/\ P7K7BGXB^/\
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9W;OI:%#%"JEVD*@ NV,M[G  _(4ZB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
